Surgery of glomus jugulare tumors

Roberto Pareschi, Stefano Righini, Domenico Destito, Aldo Falco Raucci, Stefano Colombo

Research output: Contribution to journalArticle

Abstract

The treatment of choice for glomus jugulare tumors is still controversial. High rates of morbidity, incomplete resection, and the aggressive behavior of these tumors are the main arguments for advocates of primary radiotherapy. However, constant refinements in skull base techniques have made complete resection of these lesions a realistic goal. The high probability of achieving local control of these tumors by surgery has convinced us to support this option strongly. Between 1993 and 2000 we diagnosed 52 glomus tumors of the temporal bone. Of these patients, only 42 had a class C lesion (glomus jugulare) and were included in this study; 37 of these patients underwent surgery, 10 of whom had intracranial extension of the disease. The overall resection rate was 96%. Facial nerve function at 1 year was House-Brackmann grade I to II in 52% of patients and grade III or better in 84% of patients. Hospitalization was shorter than 14 days in 33 patients (89%). All patients with pharyngolaryngeal palsy had sufficient compensation at discharge. Twelve vocal chord Teflon injections were performed after surgery to reduce hoarseness and aspiration. No patient died. No relapse was observed (mean follow-up, 4.9 years).

Original languageEnglish
Pages (from-to)149-157
Number of pages9
JournalSkull Base
Volume13
Issue number3
DOIs
Publication statusPublished - Aug 2003

Fingerprint

Glomus Jugulare Tumor
Glomus Jugulare
Glomus Tumor
Hoarseness
Temporal Bone
Skull Base
Facial Nerve
Polytetrafluoroethylene
Paralysis
Neoplasms
Hospitalization
Radiotherapy
Morbidity
Recurrence
Injections

Keywords

  • Glomus jugulare tumor
  • Infratemporal approach
  • Pharyngolaryngeal paralysis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pareschi, R., Righini, S., Destito, D., Raucci, A. F., & Colombo, S. (2003). Surgery of glomus jugulare tumors. Skull Base, 13(3), 149-157. https://doi.org/10.1055/s-2003-43325

Surgery of glomus jugulare tumors. / Pareschi, Roberto; Righini, Stefano; Destito, Domenico; Raucci, Aldo Falco; Colombo, Stefano.

In: Skull Base, Vol. 13, No. 3, 08.2003, p. 149-157.

Research output: Contribution to journalArticle

Pareschi, R, Righini, S, Destito, D, Raucci, AF & Colombo, S 2003, 'Surgery of glomus jugulare tumors', Skull Base, vol. 13, no. 3, pp. 149-157. https://doi.org/10.1055/s-2003-43325
Pareschi R, Righini S, Destito D, Raucci AF, Colombo S. Surgery of glomus jugulare tumors. Skull Base. 2003 Aug;13(3):149-157. https://doi.org/10.1055/s-2003-43325
Pareschi, Roberto ; Righini, Stefano ; Destito, Domenico ; Raucci, Aldo Falco ; Colombo, Stefano. / Surgery of glomus jugulare tumors. In: Skull Base. 2003 ; Vol. 13, No. 3. pp. 149-157.
@article{e195409769324617ad959dde3e232cc7,
title = "Surgery of glomus jugulare tumors",
abstract = "The treatment of choice for glomus jugulare tumors is still controversial. High rates of morbidity, incomplete resection, and the aggressive behavior of these tumors are the main arguments for advocates of primary radiotherapy. However, constant refinements in skull base techniques have made complete resection of these lesions a realistic goal. The high probability of achieving local control of these tumors by surgery has convinced us to support this option strongly. Between 1993 and 2000 we diagnosed 52 glomus tumors of the temporal bone. Of these patients, only 42 had a class C lesion (glomus jugulare) and were included in this study; 37 of these patients underwent surgery, 10 of whom had intracranial extension of the disease. The overall resection rate was 96{\%}. Facial nerve function at 1 year was House-Brackmann grade I to II in 52{\%} of patients and grade III or better in 84{\%} of patients. Hospitalization was shorter than 14 days in 33 patients (89{\%}). All patients with pharyngolaryngeal palsy had sufficient compensation at discharge. Twelve vocal chord Teflon injections were performed after surgery to reduce hoarseness and aspiration. No patient died. No relapse was observed (mean follow-up, 4.9 years).",
keywords = "Glomus jugulare tumor, Infratemporal approach, Pharyngolaryngeal paralysis",
author = "Roberto Pareschi and Stefano Righini and Domenico Destito and Raucci, {Aldo Falco} and Stefano Colombo",
year = "2003",
month = "8",
doi = "10.1055/s-2003-43325",
language = "English",
volume = "13",
pages = "149--157",
journal = "Skull Base",
issn = "1531-5010",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Surgery of glomus jugulare tumors

AU - Pareschi, Roberto

AU - Righini, Stefano

AU - Destito, Domenico

AU - Raucci, Aldo Falco

AU - Colombo, Stefano

PY - 2003/8

Y1 - 2003/8

N2 - The treatment of choice for glomus jugulare tumors is still controversial. High rates of morbidity, incomplete resection, and the aggressive behavior of these tumors are the main arguments for advocates of primary radiotherapy. However, constant refinements in skull base techniques have made complete resection of these lesions a realistic goal. The high probability of achieving local control of these tumors by surgery has convinced us to support this option strongly. Between 1993 and 2000 we diagnosed 52 glomus tumors of the temporal bone. Of these patients, only 42 had a class C lesion (glomus jugulare) and were included in this study; 37 of these patients underwent surgery, 10 of whom had intracranial extension of the disease. The overall resection rate was 96%. Facial nerve function at 1 year was House-Brackmann grade I to II in 52% of patients and grade III or better in 84% of patients. Hospitalization was shorter than 14 days in 33 patients (89%). All patients with pharyngolaryngeal palsy had sufficient compensation at discharge. Twelve vocal chord Teflon injections were performed after surgery to reduce hoarseness and aspiration. No patient died. No relapse was observed (mean follow-up, 4.9 years).

AB - The treatment of choice for glomus jugulare tumors is still controversial. High rates of morbidity, incomplete resection, and the aggressive behavior of these tumors are the main arguments for advocates of primary radiotherapy. However, constant refinements in skull base techniques have made complete resection of these lesions a realistic goal. The high probability of achieving local control of these tumors by surgery has convinced us to support this option strongly. Between 1993 and 2000 we diagnosed 52 glomus tumors of the temporal bone. Of these patients, only 42 had a class C lesion (glomus jugulare) and were included in this study; 37 of these patients underwent surgery, 10 of whom had intracranial extension of the disease. The overall resection rate was 96%. Facial nerve function at 1 year was House-Brackmann grade I to II in 52% of patients and grade III or better in 84% of patients. Hospitalization was shorter than 14 days in 33 patients (89%). All patients with pharyngolaryngeal palsy had sufficient compensation at discharge. Twelve vocal chord Teflon injections were performed after surgery to reduce hoarseness and aspiration. No patient died. No relapse was observed (mean follow-up, 4.9 years).

KW - Glomus jugulare tumor

KW - Infratemporal approach

KW - Pharyngolaryngeal paralysis

UR - http://www.scopus.com/inward/record.url?scp=0242383357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242383357&partnerID=8YFLogxK

U2 - 10.1055/s-2003-43325

DO - 10.1055/s-2003-43325

M3 - Article

AN - SCOPUS:0242383357

VL - 13

SP - 149

EP - 157

JO - Skull Base

JF - Skull Base

SN - 1531-5010

IS - 3

ER -